Wells Fargo & Company AVADEL PHARMACEUTICALS PLC Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Number of Shares
73,448
Previous 88,072
16.6%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%